Single-cell epigenetics and multiomics analysis in kidney research.

The rapid evolution of single-cell sequencing technologies has significantly advanced our knowledge of cellular heterogeneity and the underlying molecular basis in healthy and diseased kidneys. While single-cell transcriptomic analysis excels in characterizing cell states in the heterogeneous population, the complex regulatory mechanisms governing the gene expressions are difficult to decipher using transcriptomic data alone. Single-cell sequencing technology has recently extended to include epigenome and other modalities, allowing single-cell multiomics analysis. Especially, the integrative analysis of epigenome and transcriptome dissects the cell-specific, gene-regulatory mechanisms driving cellular heterogeneity. An increasing number of single-cell multimodal atlases are being generated in nephrology research, offering novel insights into cellular diversity and the underpinning epigenetic regulation. This ongoing paradigm shift in kidney research accelerates the identification of new biomarkers and potential therapeutic targets, promoting clinical translation. In this era of transformative nephrology research, the basic knowledge of single-cell sequencing analysis and multiomics approach is valuable not only for basic science researchers but for all nephrologists. This review overview single-cell analysis, with a focus on emerging epigenomic and multiomics approaches and their application to kidney research.